Literature DB >> 27863715

Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis.

Linny Kimly Phuong1, Caterina Bonetto2, Jim Buttery3, Yolanda Brauchli Pernus4, Rebecca Chandler5, Karen L Goldenthal6, Merita Kucuku7, Giuseppe Monaco8, Barbara Pahud9, Stanford T Shulman10, Karina A Top11, Rolando Ulloa-Gutierrez12, Frederick Varricchio13, Sarah de Ferranti14, Jane W Newburger14, Nagib Dahdah15, Surjit Singh16, Jan Bonhoeffer17, David Burgner18.   

Abstract

Entities:  

Keywords:  Adverse event; Case definition; Guidelines; Immunisation; Kawasaki disease

Mesh：

Year:  2016        PMID： 27863715     DOI： 10.1016/j.vaccine.2016.09.025

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  4 in total

Review 1.  Dissecting Kawasaki disease: a state-of-the-art review.

Authors:  S M Dietz; D van Stijn; D Burgner; M Levin; I M Kuipers; B A Hutten; T W Kuijpers
Journal:  Eur J Pediatr       Date:  2017-06-27       Impact factor: 3.183

Review 2.  Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.

Authors:  Alessandra Marchesi; Isabella Tarissi de Jacobis; Donato Rigante; Alessandro Rimini; Walter Malorni; Giovanni Corsello; Grazia Bossi; Sabrina Buonuomo; Fabio Cardinale; Elisabetta Cortis; Fabrizio De Benedetti; Andrea De Zorzi; Marzia Duse; Domenico Del Principe; Rosa Maria Dellepiane; Livio D'Isanto; Maya El Hachem; Susanna Esposito; Fernanda Falcini; Ugo Giordano; Maria Cristina Maggio; Savina Mannarino; Gianluigi Marseglia; Silvana Martino; Giulia Marucci; Rossella Massaro; Christian Pescosolido; Donatella Pietraforte; Maria Cristina Pietrogrande; Patrizia Salice; Aurelio Secinaro; Elisabetta Straface; Alberto Villani
Journal:  Ital J Pediatr       Date:  2018-08-30       Impact factor: 2.638

3.  Kawasaki Disease following administration of 13-valent pneumococcal conjugate vaccine in young children.

Authors:  Chee Fu Yung; Xiangmei Ma; Yin Bun Cheung; Bee Khiam Oh; Sally Soh; Koh Cheng Thoon
Journal:  Sci Rep       Date:  2019-10-11       Impact factor: 4.379

4.  Developing standard safety outcomes for COVID-19 vaccines.

Authors:  Jim P Buttery
Journal:  Vaccine       Date:  2021-03-12       Impact factor: 3.641
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.